Long-term anorectal function in rectal cancer patients managed by a watch-and-wait strategy after total neoadjuvant treatment: a cross-sectional study.

IF 3.3 2区 医学 Q2 ONCOLOGY
Lan-Yue Xu, Xin Jin, Hui Zhang, Xian Wu, Yan Xuan, Yun Deng, Jing-Wen Wang, Zhi-Yuan Zhang, Fan Xia, Zhen Zhang
{"title":"Long-term anorectal function in rectal cancer patients managed by a watch-and-wait strategy after total neoadjuvant treatment: a cross-sectional study.","authors":"Lan-Yue Xu, Xin Jin, Hui Zhang, Xian Wu, Yan Xuan, Yun Deng, Jing-Wen Wang, Zhi-Yuan Zhang, Fan Xia, Zhen Zhang","doi":"10.1186/s13014-025-02732-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study evaluates the long-term anorectal function and rectal toxicity in rectal cancer patients who achieved a clinical complete response (cCR) to total neoadjuvant treatment (TNT) and were managed with a watch-and-wait (W&W) approach. While oncological outcomes have been favorable, functional outcomes warrant further investigation. Additionally, this research identifies clinical risk factors of anorectal dysfunction post-treatment.</p><p><strong>Methods: </strong>This was a single-center, cross-sectional study. Rectal cancer patients who underwent TNT followed by W&W between December 2014 and November 2020 were recruited. A minimum 2-year follow-up with no disease progression was required. The study took the form of semi-structured interviews. Multiple scales for evaluation were used, including the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer (RTOG/EORTC) scale, the Late Effects of Normal Tissues/Subjective Objective Management Analytic (LENT/SOMA) system, the Wexner score, the Low Anterior Resection Syndrome (LARS) score and the Memorial Sloan Kettering Cancer Center Bowel Function Instrument (MSKCC BFI). Univariate analysis and multi-factor Logistic regression were used to identify the risk factors for anorectal dysfunction.</p><p><strong>Results: </strong>Out of 70 patients with a median follow-up of 43 months, less than half experienced grade I (28/70, 40.0%) or II (1/70, 1.4%) late rectal toxicity according to the RTOG/EORTC criteria, with no cases of more severe toxicity. The prevalence of fecal urgency was the most significant symptom reported (42/70, 60.0%). The median LARS score was 16 [interquartile ranges (IQR) 4-25]; 17.1% (12/70) of patients had minor LARS and 15.7% (11/70) had major LARS. The median Wexner score was 2 (IQR 0-3). The median MSKCC BFI total score was 82.5 (IQR 77-86). Smoking history was an independent risk factor for long-term anorectal dysfunction [odds ratio (OR) 6.562, 95% confidence interval (CI) 1.561-27.590].</p><p><strong>Conclusion: </strong>Most rectal cancer patients under a W&W strategy after TNT sustain acceptable anorectal function, though fecal urgency remains a common issue. Smoking history emerged as a significant risk factor for anorectal dysfunction. Larger prospective studies focusing on bowel function are needed.</p>","PeriodicalId":49639,"journal":{"name":"Radiation Oncology","volume":"20 1","pages":"154"},"PeriodicalIF":3.3000,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529818/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13014-025-02732-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study evaluates the long-term anorectal function and rectal toxicity in rectal cancer patients who achieved a clinical complete response (cCR) to total neoadjuvant treatment (TNT) and were managed with a watch-and-wait (W&W) approach. While oncological outcomes have been favorable, functional outcomes warrant further investigation. Additionally, this research identifies clinical risk factors of anorectal dysfunction post-treatment.

Methods: This was a single-center, cross-sectional study. Rectal cancer patients who underwent TNT followed by W&W between December 2014 and November 2020 were recruited. A minimum 2-year follow-up with no disease progression was required. The study took the form of semi-structured interviews. Multiple scales for evaluation were used, including the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer (RTOG/EORTC) scale, the Late Effects of Normal Tissues/Subjective Objective Management Analytic (LENT/SOMA) system, the Wexner score, the Low Anterior Resection Syndrome (LARS) score and the Memorial Sloan Kettering Cancer Center Bowel Function Instrument (MSKCC BFI). Univariate analysis and multi-factor Logistic regression were used to identify the risk factors for anorectal dysfunction.

Results: Out of 70 patients with a median follow-up of 43 months, less than half experienced grade I (28/70, 40.0%) or II (1/70, 1.4%) late rectal toxicity according to the RTOG/EORTC criteria, with no cases of more severe toxicity. The prevalence of fecal urgency was the most significant symptom reported (42/70, 60.0%). The median LARS score was 16 [interquartile ranges (IQR) 4-25]; 17.1% (12/70) of patients had minor LARS and 15.7% (11/70) had major LARS. The median Wexner score was 2 (IQR 0-3). The median MSKCC BFI total score was 82.5 (IQR 77-86). Smoking history was an independent risk factor for long-term anorectal dysfunction [odds ratio (OR) 6.562, 95% confidence interval (CI) 1.561-27.590].

Conclusion: Most rectal cancer patients under a W&W strategy after TNT sustain acceptable anorectal function, though fecal urgency remains a common issue. Smoking history emerged as a significant risk factor for anorectal dysfunction. Larger prospective studies focusing on bowel function are needed.

Abstract Image

Abstract Image

Abstract Image

在全新辅助治疗后通过观察和等待策略管理的直肠癌患者的长期肛肠功能:一项横断面研究。
背景:本研究评估了在全新辅助治疗(TNT)中达到临床完全缓解(cCR)的直肠癌患者的长期肛肠功能和直肠毒性,并采用观察和等待(W&W)方法进行管理。虽然肿瘤预后良好,但功能预后有待进一步研究。此外,本研究还确定了治疗后肛肠功能障碍的临床危险因素。方法:这是一项单中心、横断面研究。研究招募了2014年12月至2020年11月期间接受TNT和W&W治疗的直肠癌患者。至少2年随访,无疾病进展。这项研究采用了半结构化访谈的形式。采用多种量表进行评估,包括放射治疗肿瘤组/欧洲癌症研究和治疗组织(RTOG/EORTC)量表、正常组织的晚期效应/主客观管理分析(LENT/SOMA)系统、Wexner评分、低前切除术综合征(LARS)评分和纪念斯隆凯特琳癌症中心肠功能仪(MSKCC BFI)。采用单因素分析和多因素Logistic回归分析确定肛肠功能障碍的危险因素。结果:在中位随访43个月的70例患者中,根据RTOG/EORTC标准,不到一半的患者出现I级(28/70,40.0%)或II级(1/70,1.4%)晚期直肠毒性,没有更严重的毒性病例。大便急症是报告的最显著症状(42/70,60.0%)。LARS评分中位数为16[四分位间距(IQR) 4-25];17.1%(12/70)的患者为轻度LARS, 15.7%(11/70)的患者为重度LARS。Wexner评分中位数为2 (IQR 0-3)。MSKCC BFI总评分中位数为82.5 (IQR 77-86)。吸烟史是长期肛肠功能障碍的独立危险因素[优势比(OR) 6.562, 95%可信区间(CI) 1.561-27.590]。结论:大多数直肠癌患者在TNT后采用W&W策略,维持了可接受的肛肠功能,尽管大便急症仍然是一个常见的问题。吸烟史是肛肠功能障碍的重要危险因素。需要对肠道功能进行更大规模的前瞻性研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Radiation Oncology
Radiation Oncology ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
6.50
自引率
2.80%
发文量
181
审稿时长
3-6 weeks
期刊介绍: Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信